Showing 1611-1620 of 5603 results for "".
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
https://reachmd.com/programs/cme/Signaling-for-Sustained-Change-Spotlight-on-the-Potential-of-TKIs-to-Deliver-Durable-Control-of-Exudative-Retinal-Disease/39934/Explore the clinical promise of TKIs in managing exudative retinal diseases with insights on mechanisms, delivery, trials, and patient selection.IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
https://reachmd.com/programs/cme/igan-management-into-practice-evolving-guidelines-targeted-therapies/37238/Examine updated KDIGO 2025 IgAN guidelines and the new approach to managing proteinuria and slowing kidney function decline.No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-emerging-ckd-therapies-in-t1d/36524/Gain insights in CKD screening practices, pathophysiology, and treatment from the results of the FINE-1 trial evaluating finerenone in patients with type 1 diabetes.Shifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
https://reachmd.com/programs/cme/shifting-the-script-personalizing-overactive-bladder-treatment-in-complex-patients/54125/Examine strategies to personalize overactive bladder management, including in patients with BPH, with attention to β₃-agonists and APP-led care pathways.At the Lid Line: Unmasking Demodex Across the OSD Spectrum
https://reachmd.com/programs/cme/at-the-lid-line-unmasking-demodex-across-the-osd-spectrum/54261/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
https://reachmd.com/programs/cme/enhancing-collaborative-care-in-retinal-diseases-a-focus-on-injection-therapies/37715/Explore strategies to improve retinal disease referrals and adherence to anti-VEGF therapy through interdisciplinary collaboration.Beyond Steroidal MRAs: The Nonsteroidal MRA Lens in HF
https://reachmd.com/programs/cme/beyond-steroidal-mras-the-nonsteroidal-mra-lens-in-hf/49198/Examine how nonsteroidal MRAs inform risk-based treatment in HFpEF and HFmrEF, including stable patients with ongoing cardio-kidney-metabolic risk.It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/it-takes-a-village-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37714/Review a case of geographic atrophy highlighting care coordination gaps and quality improvement opportunities in patients who relocate seasonally for retina care.Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
https://reachmd.com/programs/cme/engaging-your-patient-shared-decision-making-in-hf-with-lvef40/29910/Engaging Your Patient: Shared Decision-Making in HF With Preserved Ejection FractionNew Product Evaluation Basics in Aesthetic Practices
https://reachmd.com/topics/injectables/new-product-evaluation-basics-in-aesthetic-practices/35166/Choice of methodology can lead to widely different conclusions: A single-center experience.